Ostatní
Návod 
Haemonetics Corporation
HAE
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
3.5B
Obrat
1B
Zisk
0B
Aktiva
2B
Dluh
1B
ROE
0%
ROA
0%
PE
16
PS
2
Cena 1R
47-87
⌀ Cena
65.91
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
05-02-2026
Poslední dividenda
Profil
Zdravotnická společnost Haemonetics Corporation poskytuje zdravotnické produkty a řešení. Působí ve třech segmentech: Plazma, Krvavé centrum a Nemocnice. Společnost nabízí automatizovaná zařízení pro sběr plazmy, související jednorázová zařízení a software, včetně zařízení pro plazmaferézu NexSys PCS a PCS2 a souvisejících jednorázových a intravenózních řešení, stejně jako integrované platformy informačních technologií pro zákazníky plazmatu pro řízení dárců, operací a dodavatelského řetězce; a systém pro řízení dárců NexLynk DMS. Poskytuje také automatizované systémy pro odběr krve a ruční systémy pro odběr krve z celého těla, jako jsou například aperézní zařízení značky MCS pro odběr specifických krevních složek od dárce, jednorázové sady pro odběr a skladování krve z celého těla, informační systém o krevní bance SafeTrace Tx a software pro řízení krve BloodTrack, sadu řešení pro řízení krve a transfuze z lůžka, která kombinuje software s hardwarovými složkami, a také rozšíření informačního systému krevní banky v nemocnici. Kromě toho společnost nabízí nemocniční produkty, které zahrnují TEG, ClotPro a HAS systémy pro analýzu hemostázy, které poskytují komplexní posouzení celkové hemostázy pacienta; software TEG Manager, který propojuje různé TEG analyzátory v celé nemocnici, poskytuje klinickým lékařům vzdálený přístup k aktivním a historickým výsledkům testů, které informují o rozhodnutí léčby; a Cell Saver Elite +, systém autologního rekonvalescence krve pro kardiovaskulární, ortopedické, traumatologické, transplantační, vaskulární, postetrické a gynekologické operace. Své výrobky prodává prostřednictvím přímých prodejců, nezávislých distributorů a obchodních zástupců. Společnost Haemonetics Corporation byla založena v roce 1971 a sídlí v Bostonu ve státě Massachusetts.
Sektor
Healthcare
Odvětví
Medical - Instruments & Supplies
Počet zaměstnanců
3657
Založení
1991-05-10
Podobné společnosti
$ 11.02
- $ 0.16
$ 17.49
+ $ 0.27
$ 68.57
+ $ 0.31
$ 20.96
+ $ 0.61
$ 86.11
- $ 0.71
$ 6.60
- $ 0.05
$ 28.16
+ $ 0.01
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 1,318.3 | 1,360.8 | 1,309.1 | 1,168.7 | 993.2 | 870.5 | 988.5 | 967.6 | 903.9 | 886.1 | 909.7 | 910.4 | 938.5 | 892.0 | 727.8 | 676.7 | 645.4 | |
| Cost of Revenues | 547.2 | 582.3 | 597.1 | 553.6 | 487.7 | 472.6 | 504.0 | 550.0 | 492.0 | 507.6 | 503.8 | 476.0 | 470.1 | 463.9 | 358.6 | 321.5 | 307.9 | |
| Gross Profit | 771.1 | 778.5 | 711.9 | 615.1 | 505.5 | 397.8 | 484.5 | 417.5 | 411.9 | 378.5 | 405.9 | 434.4 | 468.4 | 428.1 | 369.2 | 355.2 | 337.5 |
| Revenue | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 339.0 | 327.3 | 321.4 | 330.6 | 348.5 | 345.5 | 336.2 | 343.3 | 336.3 | 318.2 | |
| Cost of Revenues | 147.6 | 132.6 | 129.5 | 137.5 | 148.6 | 154.3 | 156.9 | 154.3 | 151.3 | 147.6 | |
| Gross Profit | 191.4 | 194.7 | 191.9 | 193.1 | 199.9 | 191.2 | 179.3 | 188.9 | 184.9 | 170.6 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 50.1 | 46.8 | 32.9 | 30.9 | 35.7 | 39.2 | 37.6 | 45.6 | 54.2 | 54.2 | 48.6 | 36.8 | 32.7 | 26.4 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 376.7 | 339.6 | 274.2 | 299.7 | 298.3 | 316.5 | 301.7 | 324.0 | 339.7 | 366.8 | 318.8 | 245.3 | 213.9 | 214.5 | |
| Depreciation & Amortization | 112.6 | 108.9 | 88.6 | 93.3 | 88.7 | 84.3 | 110.3 | 109.4 | 89.2 | 89.7 | 90.0 | 86.1 | 81.7 | 65.5 | 50.0 | 48.1 | 43.2 | |
| Total Operating Expenses | 517.8 | 556.7 | 547.0 | 459.1 | 433.8 | 339.9 | 330.6 | 334.0 | 355.8 | 339.3 | 369.5 | 393.9 | 421.0 | 367.4 | 282.1 | 244.7 | 240.9 | |
| Operating Income | 253.3 | 221.8 | 164.9 | 156.0 | 80.8 | 58.0 | 154.0 | 83.5 | 56.2 | -19.4 | -44.0 | 40.5 | 47.3 | 56.4 | 88.8 | 110.5 | 83.3 |
| Operating Income | TTM | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Depreciation & Amortization | 27.4 | 28.3 | 28.8 | 28.2 | 29.0 | 29.2 | 29.1 | 19.0 | 23.5 | 23.2 | ||
| Total Operating Expenses | 121.8 | 136.3 | 138.0 | 121.7 | 140.9 | 139.5 | 139.5 | 159.0 | 139.0 | 135.3 | ||
| Operating Income | 69.6 | 58.5 | 53.9 | 71.3 | 59.0 | 51.7 | 39.8 | 29.9 | 46.0 | 35.3 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 0.0 | 13.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | 0.4 | |
| Interest Expense | 20.0 | 9.7 | 13.0 | 14.6 | 17.1 | 16.8 | 16.2 | 9.9 | 4.5 | 8.1 | 9.5 | 9.4 | 10.9 | -54.7 | -54.6 | 0.0 | 0.7 | |
| Other Expense | -26.1 | -9.7 | -13.0 | -14.6 | -17.1 | 15.0 | -66.8 | -9.9 | 8.0 | -58.6 | -80.3 | -5.4 | -1.7 | -6.5 | 2.3 | -0.8 | -15.0 | |
| IBT | 227.2 | 212.1 | 151.9 | 141.4 | 63.6 | 72.9 | 87.2 | 73.6 | 59.6 | -27.5 | -53.5 | 31.2 | 36.4 | 49.9 | 89.5 | 110.1 | 81.3 | |
| Income Tax Expense | 51.7 | 44.4 | 34.3 | 26.0 | 20.3 | -6.6 | 10.6 | 18.6 | 14.1 | -1.2 | 2.2 | 14.3 | 1.3 | 11.1 | 22.6 | 30.1 | 22.9 | |
| Net Income | 175.4 | 167.7 | 117.6 | 115.4 | 43.4 | 79.5 | 76.5 | 55.0 | 45.6 | -26.3 | -55.6 | 16.9 | 35.1 | 38.8 | 66.9 | 80.0 | 58.4 |
| Net Income | TTM | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 7.0 | 0.0 | 0.0 | 0.0 | ||
| Interest Expense | 8.1 | 7.2 | 4.1 | 0.6 | 9.1 | 7.0 | 0.0 | 6.5 | 1.9 | 2.5 | ||
| Other Expense | -9.6 | -7.2 | -8.7 | -0.6 | -9.1 | -7.0 | 7.0 | -6.5 | -1.9 | -2.5 | ||
| IBT | 60.0 | 51.3 | 45.2 | 70.7 | 49.9 | 44.7 | 46.7 | 23.4 | 44.0 | 32.8 | ||
| Income Tax Expense | 15.2 | 12.6 | 11.1 | 12.8 | 12.4 | 10.9 | 8.3 | 3.0 | 12.8 | 7.9 | ||
| Net Income | 44.7 | 38.7 | 34.0 | 58.0 | 37.5 | 33.8 | 38.4 | 20.4 | 31.2 | 24.9 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $2.27 | $0.85 | $1.57 | $1.51 | $1.07 | $0.86 | $-0.51 | $-1.09 | $0.33 | $0.68 | $0.76 | $1.30 | $1.59 | $1.15 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $2.24 | $0.84 | $1.55 | $1.48 | $1.04 | $0.85 | $-0.51 | $-1.09 | $0.32 | $0.67 | $0.74 | $1.30 | $1.56 | $1.12 | |
| Shares Outstanding | 46.8 | 50.3 | 50.7 | 50.8 | 51.0 | 50.7 | 50.7 | 51.5 | 52.8 | 51.5 | 50.9 | 51.5 | 51.6 | 51.3 | 50.7 | 50.2 | 50.9 | |
| Diluted Shares Outstanding | 47.0 | 50.7 | 51.4 | 51.4 | 51.4 | 51.3 | 51.8 | 52.9 | 53.5 | 51.5 | 50.9 | 52.1 | 52.4 | 52.3 | 51.6 | 51.2 | 52.1 |
| Per Share Data | TTM | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Shares Outstanding | 46.8 | 47.6 | 48.1 | 49.2 | 50.3 | 50.9 | 50.9 | 50.8 | 50.8 | 50.7 | ||
| Diluted Shares Outstanding | 47.0 | 47.7 | 48.4 | 49.5 | 50.6 | 51.2 | 51.6 | 51.4 | 51.4 | 51.4 |
| Current Assets | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 178.8 | 306.8 | 178.8 | 284.5 | 259.5 | 192.3 | 137.3 | 169.4 | 180.2 | 139.6 | 115.1 | 160.7 | 192.5 | 179.1 | 228.9 | 196.7 | 141.6 | |
| Short Term Investments | 1.7 | 0.0 | 0.0 | 1.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 178.8 | 306.8 | 178.8 | 284.5 | 259.5 | 192.3 | 137.3 | 169.4 | 180.2 | 139.6 | 115.1 | 160.7 | 192.5 | 179.1 | 228.9 | 196.7 | 141.6 | |
| Accounts Receivable | 206.6 | 202.7 | 206.6 | 179.1 | 159.4 | 127.6 | 165.2 | 185.0 | 151.2 | 152.7 | 157.1 | 145.8 | 165.0 | 170.1 | 135.5 | 127.2 | 118.7 | |
| Inventory | 317.2 | 365.1 | 317.2 | 259.4 | 293.0 | 322.6 | 270.3 | 194.3 | 160.8 | 176.9 | 186.1 | 211.1 | 197.7 | 183.8 | 117.2 | 84.4 | 80.0 | |
| Other Current Assets | 66.3 | 60.4 | 66.3 | 46.7 | 44.1 | 51.1 | 30.8 | 27.4 | 29.0 | 40.9 | 28.8 | 50.4 | 74.6 | 64.0 | 45.1 | 40.6 | 33.5 | |
| Total Current Assets | 768.9 | 935.0 | 768.9 | 769.7 | 756.0 | 693.5 | 603.6 | 576.1 | 521.2 | 510.0 | 487.2 | 568.0 | 629.6 | 597.0 | 526.6 | 448.8 | 373.7 |
| Current Assets | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 296.4 | 292.9 | 306.8 | 320.8 | 299.3 | 344.4 | 178.8 | 194.0 | 351.0 | 285.7 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 296.4 | 292.9 | 306.8 | 320.8 | 299.3 | 344.4 | 178.8 | 194.0 | 351.0 | 285.7 | |
| Accounts Receivable | 207.1 | 200.8 | 202.7 | 211.9 | 213.5 | 201.5 | 206.6 | 211.6 | 174.2 | 177.1 | |
| Inventory | 336.2 | 360.5 | 365.1 | 359.6 | 382.1 | 373.8 | 317.2 | 304.0 | 285.8 | 289.2 | |
| Other Current Assets | 60.0 | 59.0 | 60.4 | 113.5 | 61.0 | 58.9 | 66.3 | 55.4 | 54.7 | 49.6 | |
| Total Current Assets | 899.7 | 913.2 | 935.0 | 1,005.9 | 955.9 | 978.6 | 768.9 | 765.0 | 865.7 | 801.6 |
| Long-Term Assets | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 366.6 | 284.1 | 366.6 | 310.9 | 258.5 | 217.6 | 253.4 | 344.0 | 332.2 | 323.9 | 337.6 | 321.9 | 271.4 | 257.0 | 161.7 | 155.5 | 153.3 | |
| Goodwill | 565.1 | 604.3 | 565.1 | 466.2 | 467.3 | 466.4 | 210.7 | 210.8 | 211.4 | 210.8 | 267.8 | 334.3 | 336.8 | 330.5 | 115.1 | 115.4 | 120.5 | |
| Intangible Assets | 406.1 | 455.7 | 406.1 | 275.8 | 310.3 | 365.5 | 133.1 | 127.7 | 156.6 | 177.5 | 204.5 | 244.6 | 271.2 | 264.4 | 96.5 | 101.8 | 86.1 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -6.0 | -3.9 | -4.4 | -4.0 | -4.0 | -7.1 | -581.9 | -609.1 | -596.6 | -211.6 | 0.0 | -211.6 | |
| Other Long-Term Assets | 81.1 | 164.1 | 81.1 | 107.0 | 63.2 | 76.9 | 66.3 | 16.2 | 16.0 | 16.4 | 20.0 | 593.2 | 619.8 | 608.0 | 222.3 | 10.5 | 227.2 | |
| Total Long-Term Assets | 1,426.7 | 1,516.0 | 1,426.7 | 1,165.1 | 1,103.7 | 1,126.4 | 663.5 | 698.6 | 716.2 | 728.7 | 829.9 | 915.1 | 891.2 | 864.9 | 384.0 | 384.4 | 380.5 | |
| Total Assets | 2,195.6 | 2,450.9 | 2,195.6 | 1,934.8 | 1,859.7 | 1,819.9 | 1,267.1 | 1,274.8 | 1,237.3 | 1,238.7 | 1,317.1 | 1,483.1 | 1,520.8 | 1,461.9 | 910.6 | 833.3 | 754.1 |
| Long-Term Assets | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 292.5 | 286.9 | 284.1 | 286.1 | 300.5 | 302.5 | 311.4 | 318.7 | 307.8 | 304.5 | |
| Goodwill | 606.1 | 607.3 | 604.3 | 605.3 | 616.2 | 613.3 | 565.1 | 555.0 | 465.4 | 465.9 | |
| Intangible Assets | 428.4 | 450.6 | 455.7 | 465.6 | 487.8 | 494.9 | 406.1 | 429.3 | 250.5 | 268.1 | |
| Long-Term Investments | 0.0 | 12.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 208.0 | 183.4 | 164.1 | 160.4 | 155.8 | 142.3 | 136.4 | 127.4 | 117.1 | 117.3 | |
| Total Long-Term Assets | 1,542.5 | 1,548.9 | 1,516.0 | 1,525.4 | 1,569.3 | 1,562.4 | 1,426.7 | 1,435.4 | 1,145.5 | 1,160.7 | |
| Total Assets | 2,442.2 | 2,462.1 | 2,450.9 | 2,531.3 | 2,525.2 | 2,541.0 | 2,195.6 | 2,200.4 | 2,011.3 | 1,962.3 |
| Current Liabilities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 73.4 | 67.0 | 73.4 | 63.9 | 58.4 | 50.3 | 50.7 | 63.4 | 55.3 | 43.0 | 39.7 | 48.4 | 53.6 | 49.9 | 35.4 | 28.3 | 25.6 | |
| Short-Term Debt | 18.4 | 303.6 | 10.2 | 11.8 | 214.1 | 17.0 | 77.0 | 27.7 | 194.3 | 61.0 | 43.5 | 21.5 | 45.6 | 23.2 | 0.9 | 0.9 | 17.1 | |
| Other Current Liabilities | 177.4 | 164.2 | 185.6 | 145.9 | 137.9 | 159.9 | 127.7 | 117.5 | 109.4 | 80.7 | 74.5 | 96.8 | 93.8 | 83.0 | 129.9 | 46.3 | 114.0 | |
| Current Liabilities | 300.4 | 578.1 | 300.4 | 251.8 | 442.3 | 253.5 | 284.3 | 235.8 | 384.7 | 211.2 | 184.7 | 189.1 | 217.8 | 179.8 | 130.7 | 108.7 | 131.1 |
| Current Liabilities | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 61.7 | 46.0 | 67.0 | 63.0 | 69.2 | 76.9 | 73.4 | 56.8 | 80.2 | 78.1 | |
| Short-Term Debt | 304.3 | 303.9 | 303.6 | 5.1 | 5.4 | 5.1 | 10.2 | 13.7 | 13.6 | 13.6 | |
| Other Current Liabilities | 182.3 | 132.2 | 164.2 | 149.6 | 162.6 | 144.4 | 185.6 | 191.2 | 170.5 | 145.2 | |
| Current Liabilities | 548.3 | 531.4 | 578.1 | 253.2 | 273.9 | 260.1 | 300.4 | 261.8 | 264.2 | 236.9 |
| Long-Term Liabilities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 797.6 | 921.2 | 797.6 | 754.1 | 559.4 | 690.6 | 305.5 | 322.5 | 59.4 | 253.6 | 364.5 | 406.4 | 392.1 | 456.9 | 2.9 | 4.0 | 4.6 | |
| Capital Leases | 58.0 | 0.0 | 58.0 | 63.1 | 7.2 | 70.7 | 59.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 62.6 | 62.6 | 62.6 | 36.2 | 28.7 | 47.5 | 14.0 | 22.8 | 9.4 | 13.7 | 23.7 | 32.1 | 29.7 | 29.6 | 23.3 | 18.7 | 13.5 | |
| Total Liabilities | 1,235.6 | 1,630.1 | 1,235.6 | 1,116.8 | 1,110.3 | 1,088.3 | 680.0 | 606.9 | 484.9 | 499.1 | 597.1 | 657.0 | 681.2 | 692.7 | 175.6 | 147.1 | 161.0 |
| Long-Term Liabilities | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 920.4 | 920.8 | 921.2 | 1,219.8 | 1,219.5 | 1,218.5 | 797.6 | 856.8 | 748.7 | 751.4 | |
| Capital Leases | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 58.2 | 59.5 | 62.6 | 61.5 | 62.9 | 64.8 | 62.6 | 62.2 | 34.8 | 37.3 | |
| Total Liabilities | 1,593.0 | 1,579.8 | 1,630.1 | 1,624.4 | 1,646.4 | 1,635.6 | 1,235.6 | 1,257.1 | 1,117.6 | 1,097.6 |
| Total Common Equity | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.3 | 0.3 | 0.3 | |
| Retained Earnings | 360.5 | 352.2 | 360.5 | 253.2 | 202.4 | 158.0 | 78.5 | 161.4 | 266.9 | 289.9 | 316.2 | 420.4 | 433.3 | 398.2 | 400.8 | 373.6 | 334.6 | |
| Comprehensive Income | -35.6 | -55.1 | -35.6 | -30.4 | -26.0 | -29.5 | -45.1 | -30.4 | -19.0 | -32.9 | -35.0 | -21.7 | 1.4 | 5.4 | 9.1 | 9.5 | 5.9 | |
| Total Common Equity | 960.0 | 820.8 | 960.0 | 818.0 | 749.4 | 731.7 | 587.1 | 667.9 | 752.4 | 739.6 | 720.0 | 826.1 | 839.6 | 769.2 | 735.1 | 686.1 | 593.1 |
| Total Common Equity | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | |
| Retained Earnings | 336.3 | 356.0 | 352.2 | 392.2 | 368.5 | 386.6 | 360.5 | 340.1 | 308.9 | 284.0 | |
| Comprehensive Income | -40.5 | -36.2 | -55.1 | -55.5 | -34.6 | -42.7 | -35.6 | -24.4 | -32.7 | -29.5 | |
| Total Common Equity | 849.2 | 882.3 | 820.8 | 906.9 | 878.9 | 905.4 | 960.0 | 943.3 | 893.7 | 864.6 |
| Other | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 873.9 | 1,224.8 | 807.8 | 765.9 | 773.6 | 707.6 | 382.5 | 350.1 | 253.7 | 314.6 | 408.0 | 427.9 | 437.7 | 480.1 | 3.8 | 4.9 | 21.7 | |
| Book Value | 960.0 | 820.8 | 960.0 | 818.0 | 749.4 | 731.7 | 587.1 | 667.9 | 752.4 | 739.6 | 720.0 | 826.1 | 839.6 | 769.2 | 735.1 | 686.1 | 593.1 |
| Other | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 849.2 | 882.3 | 820.8 | 906.9 | 878.9 | 905.4 | 960.0 | 943.3 | 893.7 | 864.6 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 117.6 | 167.7 | 117.6 | 115.4 | 43.4 | 79.5 | 76.5 | 55.0 | 45.6 | -26.3 | -55.6 | 16.9 | 35.1 | 38.8 | 0.8 | 0.7 | 58.4 | |
| Depreciation & Amortization | 97.2 | 115.6 | 97.2 | 93.3 | 97.7 | 84.3 | 110.3 | 109.4 | 89.2 | 89.7 | 90.0 | 86.1 | 81.7 | 65.5 | 50.0 | 48.1 | 43.2 | |
| Stock-Based Compensation | 28.3 | 29.6 | 0.0 | 25.6 | 24.4 | 25.5 | 20.5 | 17.2 | 13.0 | 9.2 | 6.9 | 14.1 | 13.1 | 11.0 | 9.3 | 10.8 | 10.3 | |
| Change Working Capital | -74.7 | -102.0 | -74.7 | 25.5 | -15.2 | -59.7 | -84.6 | -62.8 | 76.5 | -1.0 | -20.1 | -3.5 | 0.2 | -41.4 | -15.5 | -19.0 | 4.1 | |
| Change In Accounts Receivable | -24.2 | 7.0 | -24.2 | -24.4 | -35.0 | 44.1 | 18.9 | -38.1 | 5.1 | 3.2 | -10.3 | 8.8 | 6.2 | -38.1 | -10.5 | -3.9 | 4.4 | |
| Change In Accounts Payable | 44.7 | 0.0 | 44.6 | 39.8 | 7.6 | -56.4 | -17.3 | 17.7 | 0.0 | 0.0 | 0.0 | 12.7 | 3.6 | 21.6 | 22.5 | -17.0 | 12.5 | |
| Change In Inventories | -60.1 | -64.7 | -60.1 | 30.8 | 24.3 | -38.9 | -84.7 | -39.3 | 14.4 | -1.6 | 12.8 | -16.9 | -12.7 | -18.7 | -32.5 | -2.6 | -1.7 | |
| Other Non-cash Items | 36.0 | -24.0 | 52.7 | 8.5 | 16.9 | -0.9 | 42.5 | 27.1 | 1.8 | 94.9 | 101.6 | 9.4 | 9.5 | 10.6 | 65.7 | 77.7 | 12.1 | |
| Cash from Operations | 181.8 | 0.0 | 0.0 | 273.1 | 172.3 | 108.8 | 158.2 | 159.3 | 220.4 | 159.7 | 121.9 | 127.2 | 139.5 | 85.1 | 115.3 | 123.5 | 130.7 |
| Cash Flow From Operating Activities | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 44.7 | 38.7 | 34.0 | 58.0 | 37.5 | 33.8 | 38.4 | 20.4 | 31.2 | 24.9 | |
| Depreciation & Amortization | 27.4 | 28.3 | 28.8 | 28.2 | 29.0 | 29.2 | 29.1 | 27.6 | 23.5 | 23.0 | |
| Stock-Based Compensation | 7.8 | 7.6 | 9.3 | 6.9 | 0.0 | 6.9 | 0.0 | 0.0 | 7.2 | 0.0 | |
| Change Working Capital | 11.8 | 26.1 | -55.5 | 41.0 | -30.5 | -33.4 | -82.6 | 12.6 | -67.1 | 31.5 | |
| Change In Accounts Receivable | 11.1 | -7.3 | 3.6 | 10.3 | -1.8 | -9.6 | 8.0 | 3.6 | -30.6 | 1.8 | |
| Change In Accounts Payable | -6.7 | 17.7 | -47.9 | 17.6 | 3.3 | 0.0 | -44.1 | 49.5 | 0.0 | 33.7 | |
| Change In Inventories | 13.8 | 21.8 | 3.3 | 0.9 | -12.5 | -16.9 | -39.8 | -19.3 | -10.1 | -1.3 | |
| Other Non-cash Items | 3.9 | 11.4 | 4.0 | -20.9 | 10.2 | 14.7 | -12.3 | 14.5 | 7.8 | 19.7 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -66.3 | -39.3 | -66.3 | -110.2 | -96.5 | -37.0 | -48.8 | -119.0 | -74.8 | -76.1 | -102.4 | -122.2 | -73.6 | -62.2 | -53.2 | -46.7 | -56.3 | |
| Acquisitions | -240.9 | -107.6 | -240.5 | -2.0 | 8.1 | -390.2 | -25.2 | 0.0 | 9.0 | 0.0 | -3.0 | 0.0 | -32.7 | -535.2 | 0.0 | -6.4 | -77.8 | |
| Investments | -22.6 | 0.0 | -15.6 | -33.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | -16.4 | 0.0 | 0.0 | 1.6 | 2.0 | 1.8 | 16.8 | 2.8 | -72.0 | 0.0 | -101.8 | 0.0 | -73.2 | -60.2 | 1.0 | 1.5 | 1.8 | |
| Cash from Investing | -322.4 | 0.0 | 0.0 | -143.8 | -86.3 | -425.4 | -57.2 | -116.1 | -63.0 | -73.3 | -104.8 | -121.8 | -105.8 | -596.4 | -52.2 | -51.6 | -132.3 |
| Cash Flow From Investing Activities | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -6.3 | -5.0 | -3.8 | -15.6 | -8.5 | -9.4 | -5.7 | -9.7 | -14.6 | -24.7 | |
| Acquisitions | -0.4 | 0.1 | 0.3 | 45.7 | 0.3 | -1.8 | -128.8 | 2.1 | -243.9 | 0.5 | |
| Investments | 26.0 | -7.9 | -18.1 | -17.1 | 0.0 | 0.0 | 0.0 | -15.6 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -72.3 | 0.0 | 0.0 | -9.6 | -17.5 | -81.9 | -13.1 | -266.9 | -61.0 | -93.4 | -20.0 | -9.6 | -38.0 | -0.9 | -0.8 | 0.0 | -0.8 | |
| Debt Issued | 180.2 | 417.0 | 41.9 | 1.9 | 83.5 | 407.0 | 45.5 | 363.3 | 0.0 | 0.1 | 0.1 | -0.2 | -4.4 | 477.2 | -0.3 | -16.8 | 22.4 | |
| Issuance of Common Stock | 7.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.7 | 0.0 | 0.0 | |
| Repurchase of Common Stock | -11.7 | -225.0 | 0.0 | -75.0 | 0.0 | 0.0 | -175.0 | -160.0 | -100.0 | 0.0 | -61.0 | -39.0 | 0.0 | -50.0 | -50.0 | -50.0 | -40.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -15.2 | 0.0 | 0.0 | |
| Other Financing Activities | 114.7 | 0.0 | 0.0 | -15.7 | 1.8 | 449.3 | 56.9 | 376.2 | 40.3 | 33.0 | 18.4 | 15.5 | 17.3 | 512.7 | 16.6 | 31.9 | 26.8 | |
| Cash from Financing | 38.2 | 0.0 | 0.0 | -100.4 | -15.7 | 367.5 | -131.2 | -50.6 | -120.6 | -60.4 | -62.6 | -33.2 | -20.7 | 461.9 | -30.5 | -18.1 | -14.0 |
| Cash Flow From Financing Activities | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 1,224.7 | -0.1 | 0.0 | 0.0 | -0.1 | 1.4 | 415.8 | -62.8 | 108.4 | -2.7 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | -75.0 | 0.0 | -150.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -105.7 | 128.0 | -105.7 | 25.0 | 67.2 | 55.0 | -32.0 | -10.8 | 40.6 | 24.4 | -45.5 | -31.8 | 13.3 | -49.7 | 32.2 | 55.1 | -15.2 | |
| Closing Cash Balance | 178.8 | 306.8 | 178.8 | 284.5 | 259.5 | 192.3 | 137.3 | 169.4 | 180.2 | 139.6 | 115.1 | 160.7 | 192.5 | 179.1 | 228.9 | 196.7 | 141.6 |
| Cash position | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 66.9 | 3.5 | -13.9 | -14.1 | 21.6 | -45.1 | 165.6 | -15.2 | -157.0 | 65.3 | |
| Closing Cash Balance | 363.4 | 296.4 | 292.9 | 306.8 | 320.8 | 299.3 | 344.4 | 178.8 | 194.0 | 351.0 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 115.5 | 142.4 | 115.5 | 162.9 | 75.8 | 71.8 | 109.5 | 40.3 | 145.6 | 83.6 | 19.5 | 5.0 | 65.9 | 22.9 | 62.1 | 76.8 | 74.4 | |
| Real Free Cash Flow | 87.1 | 112.8 | 115.5 | 137.3 | 51.4 | 46.2 | 89.0 | 23.1 | 132.5 | 74.5 | 12.5 | -9.1 | 52.8 | 11.9 | 52.8 | 66.0 | 64.1 |
| Free Cash Flow | 3-2026 | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 87.2 | 106.3 | 13.6 | 100.9 | 35.2 | 39.4 | -33.1 | 54.4 | -15.2 | 74.5 | |
| Real Free Cash Flow | 79.4 | 98.7 | 4.3 | 94.0 | 35.2 | 32.5 | -33.1 | 54.4 | -22.4 | 74.5 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 15.7 | 66.3 | 1703.4 |
| P/S | 2.1 | 3.2 | 67.9 |
| P/B | 3.2 | 4.3 | 25.8 |
| P/FCF | 10 | 0.7 | 396.3 |
| Market cap | $3.5 | $3.5 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 27.3 % | 0 % |
| Debt to Income | 698.1 % | 902.1 % | 0 % |
| Debt to Free cash flow | 443 % | 152.3 % | 0 % |
| Interest expense percentage | 7.9 % | 1.8 % | 38.7 % |
| Current ratio | 1.6 | 2.9 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 20.7 % | 7.3 % | 0 % |
| ROA | 7.2 % | 3.8 % | 0 % |
| CapEx to Revenue | 2.3 % | 7.9 % | 10.6 % |
| RaD to Revenue | 0 % | 4.4 % | 0 % |
| ROEM | 0 | 0 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 58.5 % | 49.2 % | 79.8 % |
| Operating margin | 19.2 % | 9 % | 29.6 % |
| Net margin | 13.3 % | 6.1 % | 27.3 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0.1 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 47.0 mil | 51.5 mil |
| Employee count | 0.0 tis | 1.3 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
